MEDP
Medpace Holdings Inc
NASDAQ: MEDP · HEALTHCARE · DIAGNOSTICS & RESEARCH
$413.59
+0.96% today
Updated 2026-04-29
Market cap
$11.81B
P/E ratio
26.04
P/S ratio
4.41x
EPS (TTM)
$15.88
Dividend yield
—
52W range
$284 – $629
Volume
0.4M
Medpace Holdings Inc (MEDP) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $272.89M | $290.04M | $359.06M | $421.58M | $436.15M | $704.59M | $860.97M | $925.92M | $1.14B | $1.46B | $1.89B | $2.11B | $2.53B |
| Revenue growth (YoY) | — | +6.3% | +23.8% | +17.4% | +3.5% | +61.5% | +22.2% | +7.5% | +23.4% | +27.8% | +29.2% | +11.8% | +20.0% |
| Cost of revenue | $148.40M | $156.31M | $202.66M | $249.47M | $261.46M | $489.06M | $615.27M | $647.20M | $814.22M | $1.03B | $1.36B | $1.45B | $1.77B |
| Gross profit | $124.49M | $133.73M | $156.39M | $172.11M | $174.69M | $215.53M | $245.70M | $278.73M | $328.15M | $432.44M | $524.50M | $656.30M | $760.62M |
| Gross margin | 45.6% | 46.1% | 43.6% | 40.8% | 40.1% | 30.6% | 28.5% | 30.1% | 28.7% | 29.6% | 27.8% | 31.1% | 30.1% |
| R&D | — | — | — | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| SG&A | $34.81M | $39.37M | $56.60M | $61.51M | $63.36M | $75.68M | $94.55M | $91.46M | $107.22M | $130.10M | $159.85M | $178.68M | $197.56M |
| Operating income | $58.86M | $26.00M | $20.56M | $52.49M | $64.86M | $101.05M | $127.26M | $167.04M | $198.62M | $278.70M | $336.82M | $446.87M | $534.93M |
| Operating margin | 21.6% | 9.0% | 5.7% | 12.5% | 14.9% | 14.3% | 14.8% | 18.0% | 17.4% | 19.1% | 17.9% | 21.2% | 21.1% |
| EBITDA | $87.66M | $94.06M | $88.95M | $99.45M | $110.98M | $139.85M | $150.45M | $186.57M | $219.73M | $301.04M | $363.15M | $476.12M | $570.50M |
| EBITDA margin | 32.1% | 32.4% | 24.8% | 23.6% | 25.4% | 19.8% | 17.5% | 20.1% | 19.2% | 20.6% | 19.3% | 22.6% | 22.5% |
| EBIT | $57.15M | $26.00M | $19.43M | $41.34M | $64.50M | $101.05M | $127.26M | $167.04M | $198.62M | $278.70M | $336.82M | $446.87M | $542.38M |
| Interest expense | $18.00M | $26.46M | $27.26M | $19.38M | $7.56M | $8.16M | $1.57M | $307000.00 | $105000.00 | $2.90M | $488000.00 | $25.00M | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $24.84M | $-15.57M | $-8.67M | $13.43M | $39.12M | $73.19M | $100.44M | $145.38M | $181.85M | $245.37M | $282.81M | $404.39M | $451.12M |
| Net income growth (YoY) | — | -162.7% | +44.3% | +254.8% | +191.4% | +87.1% | +37.2% | +44.7% | +25.1% | +34.9% | +15.3% | +43.0% | +11.6% |
| Profit margin | 9.1% | -5.4% | -2.4% | 3.2% | 9.0% | 10.4% | 11.7% | 15.7% | 15.9% | 16.8% | 15.0% | 19.2% | 17.8% |